By analyzing 16,194 CD4+ cells from scRNA-seq data of basal cell carcinoma (BCC) and immunotherapy response data, we revealed that the SC-2 CD4+ cells existed in the TME of BCC (Figure 5A and B). This evidence concerns the gene CD4 and skin basal cell carcinoma.